Porsolt announces the continuation of its expansion strategy with the creation of a new preclinical Contract Research facility in San Antonio, Texas.

Commencing operations in October 2010, the new facility, under full AAALAC accreditation, will provide non-GLP and GLP specialist pharmacology services to the global pharmaceutical and biotech industry. Services will complement those provided by the parent company headquartered in France and will initially focus on abuse liability assessment of new Chemical and Biological Entities (NCEs and NBEs) in non-human primates. ...

 PRESS RELEASE Porsolt Inc. USA (Texas).rar